Document is current
Any future updates will be listed below
-
Authors
Kiss, Máté
Halasz, Laszlo
Hadadi, Eva
Berger, Wilhelm K.
Tzerpos, Petros
Poliska, Szilard
Kancheva, Daliya
Gabriel, Aurélie
Mora Barthelmess, Romina
Debraekeleer, Ayla
Brughmans, Jan
Elkrim, Yvon
Martens, Liesbet
Saeys, Yvan
Daniel, Bence
Czimmerer, Zsolt
Laoui, Damya
Nagy, Laszlo
Van Ginderachter, Jo A.
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (12Y1922N)
Stichting Tegen Kanker (F/2024/2625, F/2024/2625)
National Institutes of Health (HL170426, HL170426)
National Research, Development and Innovation Office (TKP2021-NKTA-34, 2023-1.1.1-PIACI_FÓKUSZ-2024-00036, K145994)
János Bolyai Research Scholarship (BO/00594/22/8)
- License Information
-
More Information
Article History
Received: 8 September 2024
Accepted: 10 July 2025
First Online: 23 July 2025
Change Date: 31 July 2025
Change Type: Update
Change Details: This article has been updated to correct affiliation 11.
Declarations
:
: All animal experiments were approved by the Ethical Committee for Animal Experiments of the Vrije Universiteit Brussel (licenses 15–220-3 and 19–220-8).
: Not applicable.
: B.D. is employed at Genentech Inc., South San Francisco, CA, USA and is a shareholder of Roche. All other authors have no competing interests to disclose.
